GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and a range of crops. The company was founded in 2008 and is based in Medford, Massachusetts. This security was issued by GreenLight Biosciences Holdings, PBC, whose common stock symbol is GRNA.
$0.22
As of 07/08/2022 IEX book CBOE book
2022 © Stock Market MBA, Inc.